It's a great buying opportunity in my view as we continue the move off the bottom higher.---much much higher.
I mean obviously its going to go higher at some point, but its not happening anytime soon.
At what point does your call on this "massive up-move" expire?
For journal integrity there needs to be a "use by" date. Like buying a gallon of milk.
And define a percentage for the phrase "much much higher".
You're supposed to be a trader, how smart is it to park enough money to make anything in a $24 stock that has to sit for weeks on end? And even if it does creep up, its not going to take out $27.50 for months.
I mean B1... and I mean no disrespect... but you're not real bright when it comes to trading bro.
You can buy the January 2022 at the money calls right now for $2.75.
Not a typo...
2022.
The option writers are saying it won't be over $26.75 until 2022. You think they give away money? This is an ETF B1, its not a biotech working on a cure for the pandemic. (Which as a comical aside... you denied existed for the last 4 months, until Trump called it that.)
So... put a time stamp and percentage on these calls of "massive massive up-moves", otherwise you just sound stupid like you did with the pandemic denial and the mask denial.
I've said my peace on that. I will no longer respond to anything you say about the XLF. There is no massive move coming for the foreseeable future.
Case closed.